UltraCD40L

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameUltraCD40L
Drug Alias Namedual CD40 costimulator/surfactant protein D (Multimeric Biotherapeutics)4-trimer SP-D-CD40L (Multimeric Biotherapeutics)SP-D-CD40L
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionTumor necrosis factor receptor superfamily member 5 agonists
TargetsTumor necrosis factor receptor superfamily member 5
Therapy Area/IndicationsVaccinationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMultimeric Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMultimeric Biotherapeutics Inc
Active IndicationsN/A
Inactive IndicationsVaccinationNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A